Compare Eni SpA (E) vs Teladoc Health Inc (TDOC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eni SpA vs Teladoc Health Inc — how do they compare? Eni SpA trades at $48.34 (market cap $70.34B), while Teladoc Health Inc trades at $9.57 (market cap $1.75B). The key difference: Eni SpA is far larger — about 40.2× Teladoc Health Inc's market cap, and Eni SpA pays a 4.99% dividend while Teladoc Health Inc pays none. Which is the better fit depends on your goals.
| E | TDOC | |
|---|---|---|
Market Cap | $70.34B | $1.75B |
Sector | Energy | Health |
52-Week High | $57.61 | $9.72 |
52-Week Low | $32.93 | $4.47 |
Enterprise Value | $89.25B | $2.04B |
Dividend Yield | 4.99% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Eni (E) trades at $49.55, up 0.22% with a bullish technical signal supported by moving averages. The company shows stable cash flow generation with $238M net cash flow in 2025 and maintains a dividend of $0.63. Recent strategic expansions into renewable fuels, lithium, and energy trading through partnerships with BMW, Mercuria, and UKAEA highlight diversification efforts. Valuation metrics appear reasonable with P/E of 21.6 and EV/EBITDA of 3.83, though revenue has declined from $132.5B in 2022 to $82.15B in 2025.
The outlook balances strategic growth initiatives against revenue pressures. Opportunities exist in energy transition projects and trading expansion, but risks include oil price volatility and execution challenges. Analyst sentiment is mixed with 34.6% buy ratings versus 61.5% hold, suggesting cautious optimism. The stock's investment case hinges on successful diversification while managing core energy market exposure.
TDOC trades at $9.27, down 3.94% on the day, with a bullish technical signal from moving averages. The company reported revenue of $2.53B in 2025 but posted a net loss of $200.32M. Recent news highlights the Walmart partnership expansion and upcoming Q2 2026 earnings. Analyst consensus is mixed with 35.71% buy ratings but a price target below current levels at $8.75.
The outlook remains cautious due to persistent losses despite revenue stability. Investment opportunity exists if cost controls and partnerships drive profitability. Key risks include competitive pressures, weak BetterHelp segment, and negative cash flow trends. The stock faces headwinds until sustainable earnings improvement is demonstrated.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eni SpA
Eni is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, the company produced 0.8 million barrels of liquids and 4.6 billion cubic feet of natural gas per day. At end-2021, Eni held reserves of 6.6 billion barrels of oil equivalent, 49% of which are liquids. The Italian government owns a 30.1% stake in the company. Eni is placing its renewable and low-carbon business in a separate entity, Plentitude
Read more on E →About Teladoc Health Inc
Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.
Read more on TDOC →
